Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06281977
PHASE3

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

Sponsor: Ottawa Heart Institute Research Corporation

View on ClinicalTrials.gov

Summary

The objective of this study is to determine if there is a meaningful benefit to using the sedative medication dexmedetomidine in the acute treatment of patients with recurrent ventricular arrhythmias, known as electrical storm. This will be a multi-centre, double-blinded, placebo-controlled, randomized trial. Patients with electrical storm will be randomized to receive 48 to 72 hours of dexmedetomidine or placebo as part of their initial treatment in an intensive care unit.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

192

Start Date

2024-05-08

Completion Date

2027-08-01

Last Updated

2025-12-17

Healthy Volunteers

No

Interventions

DRUG

Dexmedetomidine

Dose range: 0.3 mcg/kg/hr to 1 mcg/kg/hr.

DRUG

Normal saline

Programed as dexmedetomidine on infusion pump.

Locations (1)

University of Ottawa Heart Institute

Ottawa, Ontario, Canada